A method for treating amyotrophic lateral sclerosis includes administering an effective amount of 3-methyl-l-phenyl-2-pyrazolin-5-one or a physiologically acceptable salt thereof to a patient who is in need thereof and meets two or more features selected from a group of identified features.
展开▼
